Dolby Laboratories DLB
NYSE DLB
$65.21 +1.02 (+1.60%)
As of: Aug 21, 2026 · 12:05 PM EDT

Dolby Laboratories (DLB) Cash from Restructuring (2019 - 2020)

Dolby Laboratories' (DLB) quarterly Cash from Restructuring came in at $8.1 million in Q4 2020, up 1571.81% YoY from $486000.0 in Q4 2019, and up 3982.91% on a QoQ basis from $199000.0 in Q3 2020.

Dolby Laboratories (DLB) Cash from Restructuring (2019 - 2020) Analysis & Trends

Dolby Laboratories (DLB) has 2 years of Cash from Restructuring data on file, last reported at $8.1 million in Q4 2020.

  • Quarterly Cash from Restructuring rose 1571.81% year-over-year to $8.1 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $9.3 million (down 72.5% YoY) and the FY2020 annual result came in at $1.6 million, down 95.07% from the prior year.
  • Cash from Restructuring rose to $8.1 million in Q4 2020, from $199000.0 in the prior quarter.
  • In the past five years, Cash from Restructuring ranged from a high of $27.5 million in Q2 2019 to a low of $116000.0 in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Cintas 81.91 Bn 81.62 Bn 1.48 Bn
2 Relx 65.84 Bn 65.66 Bn -
3 Copart 31.99 Bn 28.63 Bn 732.88 Mn
4 Global Payments 25.51 Bn 20.10 Bn 2.03 Bn
5 Rb Global 16.15 Bn 15.63 Bn 935.50 Mn
6 Aramark 15.60 Bn 15.10 Bn 430.34 Mn
7 UL Solutions 15.07 Bn 14.64 Bn 417.00 Mn
8 Rentokil Initial 11.94 Bn 9.41 Bn -
9 Dolby Laboratories 6.15 Bn 5.48 Bn 264.68 Mn
10 Unifirst 5.26 Bn 5.09 Bn 234.73 Mn

Historic Data

Download Data
DateValue
Dec 25, 2020 8.13 Mn
Sep 25, 2020 199,000.00
Jun 26, 2020 839,000.00
Mar 27, 2020 116,000.00
Dec 27, 2019 486,000.00
Sep 27, 2019 5.79 Mn
Jun 28, 2019 27.46 Mn